Home>Topics>>Baxter's Earnings Call Reveals Good News For Halozyme
Baxter's Earnings Call Reveals Good News For Halozyme
Long Investing Ideas from Seeking Alpha
Thu, 24 Jan 2013
By PropThink : By Jake King Baxter International ( BAX ) reported financial results for the fourth quarter and full-year 2012, and in a conference call following the press release, expressed confidence that HyQvia, a subcuta neous (( SC)) ver sion of Baxter's blockbuster Gammagard product, is up ...
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.